Recent advances in physicochemical and ADMET profiling in drug discovery

Area of Science:

• Pharmacology and Drug Discovery
• Computational Chemistry
• Biotechnology

Background:

• Rising drug discovery costs and high attrition rates necessitate strategic shifts.
• Traditional methods often assess drug properties late in development, leading to inefficiencies.

Purpose of the Study:

• To review advances in accurately assessing drug physicochemical and ADMET properties.
• To highlight the importance of integrated risk assessment in drug discovery.
• To present the impact of these tools on in vitro-in vivo correlation (IVIVC) and structure-property relationship (SPR) development.

Main Methods:

• Review of recent advancements in solubility and physicochemical parameter assessment.
• Discussion of profiling paradigms and integrated risk assessment strategies.
• Analysis of how in vitro data interpretation aids drug candidate optimization.

Main Results:

• Accurate assessment of drug properties alongside efficacy is crucial for modern drug discovery.
• Integrated risk assessment using profiling parameters enhances predictive power of in vitro tools.
• Proper interpretation of experimental data facilitates rapid risk assessment and rational drug optimization.

Conclusions:

• Shifting drug discovery strategy to parallel assessment of comprehensive properties improves efficiency.
• Advanced in vitro tools and integrated risk assessment are key to successful drug development.
• These methods significantly assist in establishing IVIVC and SPR for better drug candidates.